Yanying Yu

1.1k total citations
42 papers, 662 citations indexed

About

Yanying Yu is a scholar working on Molecular Biology, Infectious Diseases and Immunology. According to data from OpenAlex, Yanying Yu has authored 42 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Infectious Diseases and 9 papers in Immunology. Recurrent topics in Yanying Yu's work include SARS-CoV-2 and COVID-19 Research (11 papers), CRISPR and Genetic Engineering (7 papers) and interferon and immune responses (4 papers). Yanying Yu is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (11 papers), CRISPR and Genetic Engineering (7 papers) and interferon and immune responses (4 papers). Yanying Yu collaborates with scholars based in China, United States and Germany. Yanying Yu's co-authors include R. Grob, Peter Staeheli, Qiang Ding, Chase L. Beisel, Lars Barquist, Xiaohui Ju, Christoph Schoen, Oliver Kurzai, Gaurav Dugar and Thorsten Bischler and has published in prestigious journals such as Science, Nucleic Acids Research and Nature Communications.

In The Last Decade

Yanying Yu

39 papers receiving 659 citations

Peers

Yanying Yu

IMMUN

PHEOH

Sandra Li Belgium

Andrew T. Hutchinson Australia

Simeone Dal Monego Italy

Xiaowen Liu China

Cindy Gutzeit United States

Sonia Zicari United States

Juan Min China

Jacob S. Leiby United States

Jennifer A. Bartlett United States

Espiridión Ramos-Martı́nez Mexico

Sandra Li Belgium

Yanying Yu

135 ×0.5

409 ×2.1

110 ×0.9

IMMUN

47 ×0.8

PHEOH

28 ×0.5

Citations per year, relative to Yanying Yu Yanying Yu (= 1×) peers Sandra Li

Countries citing papers authored by Yanying Yu

Since Specialization

Citations

This map shows the geographic impact of Yanying Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanying Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanying Yu more than expected).

Fields of papers citing papers by Yanying Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanying Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanying Yu. The network helps show where Yanying Yu may publish in the future.

Co-authorship network of co-authors of Yanying Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanying Yu. A scholar is included among the top collaborators of Yanying Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanying Yu. Yanying Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dong, Huijun, Fei Ye, Qi Peng, et al.. (2025). Vesicle-associated membrane protein 5 is an intrinsic defense factor for embryonic stem cells against coronaviruses. Nature Communications. 16(1). 6241–6241. 1 indexed citations

Yu, Yanying, et al.. (2024). Drupacine as a potent SARS-CoV-2 replication inhibitor in vitro. Biosafety and Health. 6(5). 270–278.

Vento, Justin M., Tianyu Li, Constantinos Patinios, et al.. (2024). A cell-free transcription-translation pipeline for recreating methylation patterns boosts DNA transformation in bacteria. Molecular Cell. 84(14). 2785–2796.e4. 10 indexed citations

Yang, Shimin, Jiejie Liu, Yanying Yu, et al.. (2024). Natural evidence of coronaviral 2′-O-methyltransferase activity affecting viral pathogenesis via improved substrate RNA binding. Signal Transduction and Targeted Therapy. 9(1). 140–140. 3 indexed citations

Luo, Lingling, Xiaohui Ju, Shisheng Huang, et al.. (2024). Viral N protein hijacks deaminase-containing RNA granules to enhance SARS-CoV-2 mutagenesis. The EMBO Journal. 43(24). 6444–6468. 2 indexed citations

Yu, Yanying, et al.. (2024). Improved prediction of bacterial CRISPRi guide efficiency from depletion screens through mixed-effect machine learning and data integration. Genome biology. 25(1). 13–13. 17 indexed citations

Yang, Bo, Chao Liu, Xiaohui Ju, et al.. (2023). A tissue specific-infection mouse model of SARS-CoV-2. Cell Discovery. 9(1). 43–43. 5 indexed citations

Ju, Xiaohui, Ziqiao Wang, Pengcheng Wang, et al.. (2023). SARS-CoV-2 main protease cleaves MAGED2 to antagonize host antiviral defense. mBio. 14(4). e0137323–e0137323. 11 indexed citations

Ju, Xiaohui, Yanying Yu, Wenlin Ren, et al.. (2023). The PRMT5/WDR77 complex restricts hepatitis E virus replication. PLoS Pathogens. 19(6). e1011434–e1011434. 7 indexed citations

10.

Deng, Jian, Yang Xiao, Mei‐Ling Nan, et al.. (2023). SARS‐CoV‐2 NSP8 suppresses type I and III IFN responses by modulating the RIG‐I/MDA5, TRIF, and STING signaling pathways. Journal of Medical Virology. 95(4). e28680–e28680. 20 indexed citations

11.

Ren, Wenlin, Xiaohui Ju, Mingli Gong, et al.. (2022). Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion. mBio. 13(2). e0009922–e0009922. 23 indexed citations

12.

Chi, Xiaojing, Xinhui Zhang, Yanying Yu, et al.. (2022). An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants. Signal Transduction and Targeted Therapy. 7(1). 44–44. 39 indexed citations

13.

Yu, Yanying, et al.. (2022). A target expression threshold dictates invader defense and prevents autoimmunity by CRISPR-Cas13. Cell Host & Microbe. 30(8). 1151–1162.e6. 21 indexed citations

14.

Ren, Wenlin, Jun Lan, Xiaohui Ju, et al.. (2021). Mutation Y453F in the spike protein of SARS-CoV-2 enhances interaction with the mink ACE2 receptor for host adaption. PLoS Pathogens. 17(11). e1010053–e1010053. 48 indexed citations

15.

Huang, Wenjie, Xiaohui Ju, Min Tian, et al.. (2021). Molecular determinants for regulation of G3BP1/2 phase separation by the SARS-CoV-2 nucleocapsid protein. Cell Discovery. 7(1). 19 indexed citations

16.

Li, Shaoping, et al.. (2021). Association of dietary diversity and cognition in preschoolers in rural China. Nutrition. 91-92. 111470–111470. 6 indexed citations

17.

Shao, Jiang, Daming Zhang, Chenyang Qiu, et al.. (2020). Long-term outcomes of conservative treatment and endovascular treatment in patients with symptomatic spontaneous isolated superior mesenteric artery dissection: a single-center experience. BMC Cardiovascular Disorders. 20(1). 256–256. 13 indexed citations

18.

Zhang, Xiao, Yanying Yu, Kun Yang, et al.. (2020). Clinical outcomes of radiation-induced carotid stenosis: A systematic review and meta-analysis. Journal of Stroke and Cerebrovascular Diseases. 29(8). 104929–104929. 8 indexed citations

19.

Yu, Yanying, et al.. (2020). Whole genome sequencing of Thaumetopoea pityocampa revealed putative pesticide targets. Genomics. 112(6). 4203–4207. 4 indexed citations

20.

Li, Shaoping, Kevin Chen, Chengfang Liu, et al.. (2020). Dietary diversity and mental health in preschoolers in rural China. Public Health Nutrition. 24(7). 1869–1876. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact